Investigating the role of glutaredoxin and glutathione in lung cancer
Glutaredoxin, Glutathione Metabolism and Lung Cancer
This study is looking at how a substance called glutathione, which helps protect our cells, is connected to lung cancer, especially in patients with a specific gene change, and it hopes to find new ways to improve treatment for those affected.
Quick facts
| Grant type | R01 grant |
|---|---|
| Study type | NIH-funded research |
| Funding institution | University of Vermont & St Agric College NIH-funded |
| Lab location | 1 site (Burlington, United States) |
| Project ID | NIH-11139436 on NIH RePORTER |
What this research studies
This research focuses on understanding how glutathione, an important antioxidant, is involved in lung cancer, particularly in cases with KRAS mutations. The study examines the role of glutaredoxin, an enzyme that regulates glutathione levels and redox signaling, and how its disruption may contribute to lung adenocarcinoma. By analyzing protein modifications and cellular mechanisms, the research aims to uncover potential therapeutic targets for improving lung cancer treatment.
Who could benefit from this research
Good fit: Ideal candidates for this research are patients diagnosed with KRAS-mutant lung adenocarcinoma.
Not a fit: Patients with lung cancer that does not involve KRAS mutations may not benefit from this research.
Why it matters
Potential benefit: If successful, this research could lead to new strategies for treating lung cancer by targeting the glutaredoxin and glutathione pathways.
How similar studies have performed: Other research has shown promising results in targeting redox signaling pathways in cancer, suggesting that this approach may be viable.
Where this research is happening
Burlington, United States
- University of Vermont & St Agric College — Burlington, United States (Active)
Researchers
- Principal investigator: Janssen-Heininger, Yvonne M. W. — University of Vermont & St Agric College
- Study coordinator: Janssen-Heininger, Yvonne M. W.
About this research
- This is an active NIH-funded research project — typically early-stage science, not a clinical trial accepting patient enrollment.
- Some NIH-funded labs run parallel clinical studies or seek volunteers for related work. To check, contact the principal investigator or institution listed above.
- For full project details, budget, and progress reports, visit the official NIH RePORTER page below.